Concepts (252)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Body Temperature | 2 | 2022 | 124 | 0.880 |
Why?
|
| Heat Stroke | 4 | 2023 | 9 | 0.860 |
Why?
|
| Epilepsy | 8 | 2023 | 397 | 0.860 |
Why?
|
| Bioterrorism | 5 | 2007 | 18 | 0.850 |
Why?
|
| Anthrax | 5 | 2007 | 30 | 0.840 |
Why?
|
| Anticonvulsants | 8 | 2021 | 126 | 0.840 |
Why?
|
| Telemetry | 1 | 2022 | 38 | 0.840 |
Why?
|
| Epilepsies, Partial | 5 | 2023 | 42 | 0.820 |
Why?
|
| Patient Satisfaction | 4 | 2001 | 455 | 0.550 |
Why?
|
| Epilepsy, Reflex | 3 | 2015 | 7 | 0.500 |
Why?
|
| Heat Stress Disorders | 2 | 2022 | 11 | 0.420 |
Why?
|
| Bacillus anthracis | 2 | 2003 | 73 | 0.410 |
Why?
|
| Emergency Service, Hospital | 5 | 2007 | 484 | 0.400 |
Why?
|
| Exercise | 3 | 2023 | 315 | 0.360 |
Why?
|
| Inhalation Exposure | 2 | 2007 | 28 | 0.350 |
Why?
|
| Inservice Training | 2 | 1999 | 38 | 0.340 |
Why?
|
| Neurotensin | 2 | 2018 | 10 | 0.320 |
Why?
|
| Intellectual Disability | 2 | 2021 | 186 | 0.320 |
Why?
|
| Young Adult | 14 | 2023 | 5980 | 0.310 |
Why?
|
| Facial Muscles | 2 | 2008 | 23 | 0.300 |
Why?
|
| Drug Resistant Epilepsy | 2 | 2017 | 42 | 0.300 |
Why?
|
| Respiratory Tract Infections | 3 | 2003 | 105 | 0.300 |
Why?
|
| Acetamides | 2 | 2017 | 26 | 0.290 |
Why?
|
| Hippocampus | 2 | 2017 | 442 | 0.290 |
Why?
|
| Myoclonic Epilepsy, Juvenile | 1 | 2006 | 2 | 0.290 |
Why?
|
| Guidelines as Topic | 2 | 2007 | 162 | 0.270 |
Why?
|
| Disease Outbreaks | 2 | 2004 | 154 | 0.270 |
Why?
|
| Energy Metabolism | 2 | 2018 | 271 | 0.270 |
Why?
|
| Spores, Bacterial | 2 | 2003 | 18 | 0.270 |
Why?
|
| Hot Temperature | 3 | 2021 | 206 | 0.260 |
Why?
|
| Adult | 19 | 2023 | 25657 | 0.250 |
Why?
|
| Adolescent | 12 | 2023 | 8984 | 0.230 |
Why?
|
| Epilepsy, Generalized | 1 | 2023 | 37 | 0.230 |
Why?
|
| Hypothermia | 1 | 2023 | 26 | 0.230 |
Why?
|
| Vancomycin | 1 | 2023 | 72 | 0.230 |
Why?
|
| Virginia | 6 | 2019 | 16 | 0.230 |
Why?
|
| Vigabatrin | 1 | 2002 | 3 | 0.220 |
Why?
|
| Nipecotic Acids | 1 | 2002 | 5 | 0.220 |
Why?
|
| Premedication | 1 | 2002 | 54 | 0.220 |
Why?
|
| Hypercapnia | 1 | 2022 | 43 | 0.220 |
Why?
|
| Capsules | 1 | 2022 | 38 | 0.220 |
Why?
|
| Nursing Staff, Hospital | 2 | 1999 | 42 | 0.210 |
Why?
|
| Hypothalamic Area, Lateral | 2 | 2018 | 11 | 0.210 |
Why?
|
| Mediastinal Diseases | 1 | 2001 | 21 | 0.200 |
Why?
|
| Compassionate Use Trials | 1 | 2021 | 8 | 0.200 |
Why?
|
| Carbon Dioxide | 1 | 2022 | 188 | 0.200 |
Why?
|
| Football | 1 | 2022 | 43 | 0.200 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2021 | 13 | 0.200 |
Why?
|
| Running | 1 | 2021 | 25 | 0.200 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2021 | 36 | 0.190 |
Why?
|
| Temperature | 1 | 2022 | 396 | 0.190 |
Why?
|
| Seizures | 3 | 2023 | 297 | 0.190 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2001 | 74 | 0.190 |
Why?
|
| Air Pressure | 1 | 2020 | 7 | 0.190 |
Why?
|
| Humans | 29 | 2023 | 86656 | 0.190 |
Why?
|
| Patient Care | 1 | 2001 | 100 | 0.190 |
Why?
|
| Hand Strength | 1 | 2020 | 51 | 0.180 |
Why?
|
| Leptin | 2 | 2018 | 105 | 0.180 |
Why?
|
| Locomotion | 2 | 2018 | 131 | 0.180 |
Why?
|
| Electroencephalography | 4 | 2023 | 709 | 0.180 |
Why?
|
| Acclimatization | 1 | 2020 | 76 | 0.180 |
Why?
|
| Neurons | 3 | 2018 | 1547 | 0.180 |
Why?
|
| Emergency Nursing | 1 | 1999 | 7 | 0.180 |
Why?
|
| Education, Nursing, Continuing | 1 | 1999 | 9 | 0.180 |
Why?
|
| Patient Participation | 1 | 2001 | 216 | 0.170 |
Why?
|
| Anesthesiology | 1 | 2001 | 157 | 0.170 |
Why?
|
| Body Weight | 2 | 2018 | 458 | 0.170 |
Why?
|
| Hypothermia, Induced | 1 | 2019 | 74 | 0.170 |
Why?
|
| Orexins | 1 | 2018 | 8 | 0.170 |
Why?
|
| Adaptation, Psychological | 1 | 1999 | 157 | 0.160 |
Why?
|
| Professional-Patient Relations | 1 | 1998 | 53 | 0.160 |
Why?
|
| Adiposity | 1 | 2018 | 70 | 0.160 |
Why?
|
| Male | 19 | 2023 | 40984 | 0.160 |
Why?
|
| Tuberous Sclerosis | 1 | 2018 | 28 | 0.160 |
Why?
|
| Quality of Health Care | 1 | 2001 | 381 | 0.160 |
Why?
|
| Retrospective Studies | 9 | 2023 | 8495 | 0.160 |
Why?
|
| Malformations of Cortical Development | 1 | 2017 | 39 | 0.150 |
Why?
|
| Receptors, Leptin | 1 | 2017 | 32 | 0.150 |
Why?
|
| Ghrelin | 1 | 2017 | 29 | 0.150 |
Why?
|
| Patient Education as Topic | 2 | 2016 | 351 | 0.140 |
Why?
|
| Anxiety Disorders | 1 | 2017 | 148 | 0.140 |
Why?
|
| Depressive Disorder | 1 | 2017 | 218 | 0.140 |
Why?
|
| Death, Sudden | 1 | 2016 | 40 | 0.140 |
Why?
|
| Child | 7 | 2021 | 6928 | 0.130 |
Why?
|
| Quality Assurance, Health Care | 2 | 1999 | 219 | 0.130 |
Why?
|
| Feeding Behavior | 1 | 2018 | 324 | 0.130 |
Why?
|
| Quinazolinones | 1 | 2015 | 13 | 0.130 |
Why?
|
| Single-Blind Method | 3 | 2022 | 153 | 0.130 |
Why?
|
| Hypoxia | 1 | 2020 | 641 | 0.130 |
Why?
|
| Counseling | 1 | 2016 | 145 | 0.120 |
Why?
|
| Female | 15 | 2023 | 44547 | 0.120 |
Why?
|
| Middle Aged | 12 | 2021 | 25036 | 0.120 |
Why?
|
| Pyridones | 1 | 2014 | 51 | 0.120 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 1802 | 0.120 |
Why?
|
| Delivery of Health Care | 1 | 2018 | 426 | 0.110 |
Why?
|
| Photic Stimulation | 1 | 2015 | 494 | 0.110 |
Why?
|
| Personnel Management | 1 | 1992 | 7 | 0.110 |
Why?
|
| Dioxolanes | 1 | 2012 | 8 | 0.110 |
Why?
|
| Germany | 3 | 2018 | 72 | 0.100 |
Why?
|
| Postal Service | 2 | 2002 | 17 | 0.100 |
Why?
|
| Brain Neoplasms | 1 | 2017 | 763 | 0.100 |
Why?
|
| Drug Monitoring | 1 | 2012 | 118 | 0.100 |
Why?
|
| Oxygen | 2 | 2022 | 726 | 0.100 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 636 | 0.100 |
Why?
|
| Child, Preschool | 4 | 2021 | 3613 | 0.090 |
Why?
|
| Altitude Sickness | 2 | 2020 | 10 | 0.090 |
Why?
|
| Altitude | 2 | 2020 | 40 | 0.090 |
Why?
|
| Mice | 5 | 2023 | 11356 | 0.090 |
Why?
|
| Animals | 7 | 2023 | 26590 | 0.090 |
Why?
|
| Models, Theoretical | 1 | 1992 | 482 | 0.090 |
Why?
|
| Cytokines | 2 | 2023 | 778 | 0.090 |
Why?
|
| Hospital-Patient Relations | 2 | 1999 | 2 | 0.090 |
Why?
|
| Brain | 2 | 2017 | 2216 | 0.080 |
Why?
|
| Drug Synergism | 2 | 2015 | 303 | 0.080 |
Why?
|
| Comorbidity | 2 | 2017 | 944 | 0.080 |
Why?
|
| Drug Therapy, Combination | 3 | 2017 | 895 | 0.080 |
Why?
|
| Treatment Outcome | 5 | 2021 | 7998 | 0.080 |
Why?
|
| Physicians | 1 | 2016 | 674 | 0.080 |
Why?
|
| Pediatrics | 2 | 2016 | 344 | 0.080 |
Why?
|
| Electromyography | 1 | 2008 | 184 | 0.080 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2008 | 201 | 0.080 |
Why?
|
| Medical Audit | 1 | 2007 | 40 | 0.070 |
Why?
|
| Biological Warfare | 2 | 2004 | 6 | 0.070 |
Why?
|
| Age Factors | 3 | 2017 | 1851 | 0.070 |
Why?
|
| Mouth | 1 | 2006 | 48 | 0.070 |
Why?
|
| Videotape Recording | 1 | 2006 | 47 | 0.070 |
Why?
|
| Triage | 1 | 2007 | 108 | 0.070 |
Why?
|
| Evoked Potentials | 2 | 2008 | 190 | 0.070 |
Why?
|
| Aged | 6 | 2021 | 18421 | 0.070 |
Why?
|
| Austria | 2 | 2016 | 19 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2008 | 579 | 0.060 |
Why?
|
| Neuropsychological Tests | 1 | 2006 | 502 | 0.060 |
Why?
|
| Public Health Practice | 1 | 2003 | 11 | 0.060 |
Why?
|
| Survivors | 2 | 2002 | 226 | 0.060 |
Why?
|
| Kindling, Neurologic | 1 | 2002 | 2 | 0.060 |
Why?
|
| Culture Techniques | 1 | 2002 | 91 | 0.060 |
Why?
|
| Physical Endurance | 1 | 2022 | 9 | 0.060 |
Why?
|
| Guinea Pigs | 1 | 2002 | 171 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 3095 | 0.050 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2002 | 83 | 0.050 |
Why?
|
| Chemokines | 1 | 2022 | 73 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2008 | 1204 | 0.050 |
Why?
|
| Amino Acids | 1 | 2023 | 252 | 0.050 |
Why?
|
| Magnesium | 1 | 2002 | 177 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2022 | 2768 | 0.050 |
Why?
|
| District of Columbia | 1 | 2001 | 20 | 0.050 |
Why?
|
| Clindamycin | 1 | 2001 | 13 | 0.050 |
Why?
|
| Lymphatic Diseases | 1 | 2001 | 36 | 0.050 |
Why?
|
| Rifampin | 1 | 2001 | 22 | 0.050 |
Why?
|
| Ciprofloxacin | 1 | 2001 | 29 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2006 | 1564 | 0.050 |
Why?
|
| Pleural Effusion | 1 | 2001 | 45 | 0.050 |
Why?
|
| Blood | 1 | 2001 | 69 | 0.050 |
Why?
|
| Epileptic Syndromes | 1 | 2021 | 4 | 0.050 |
Why?
|
| Fenfluramine | 1 | 2021 | 20 | 0.050 |
Why?
|
| Oxygen Consumption | 1 | 2022 | 239 | 0.050 |
Why?
|
| Body Temperature Regulation | 1 | 2021 | 56 | 0.050 |
Why?
|
| Exercise Test | 1 | 2022 | 164 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2002 | 2587 | 0.050 |
Why?
|
| Occupational Diseases | 1 | 2002 | 55 | 0.050 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2021 | 7 | 0.050 |
Why?
|
| Spasms, Infantile | 1 | 2021 | 30 | 0.050 |
Why?
|
| Dyspnea | 1 | 2001 | 73 | 0.050 |
Why?
|
| Karyotyping | 1 | 2021 | 250 | 0.050 |
Why?
|
| Hospital Bed Capacity, 500 and over | 2 | 1998 | 5 | 0.050 |
Why?
|
| Fever | 1 | 2001 | 125 | 0.050 |
Why?
|
| Occupational Exposure | 1 | 2001 | 80 | 0.050 |
Why?
|
| Acetazolamide | 1 | 2020 | 9 | 0.050 |
Why?
|
| Environmental Exposure | 1 | 2003 | 296 | 0.050 |
Why?
|
| Seasons | 1 | 2022 | 223 | 0.050 |
Why?
|
| Anaerobic Threshold | 1 | 2020 | 4 | 0.050 |
Why?
|
| Intestines | 1 | 2023 | 411 | 0.050 |
Why?
|
| Humidity | 1 | 2020 | 89 | 0.050 |
Why?
|
| Mass Screening | 1 | 2004 | 619 | 0.050 |
Why?
|
| Precipitating Factors | 1 | 2019 | 5 | 0.040 |
Why?
|
| Radiography, Thoracic | 1 | 2001 | 320 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 1961 | 0.040 |
Why?
|
| Nerve Net | 2 | 2017 | 366 | 0.040 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2020 | 113 | 0.040 |
Why?
|
| Respiratory Mechanics | 1 | 2020 | 102 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2001 | 928 | 0.040 |
Why?
|
| Professional-Family Relations | 1 | 1999 | 48 | 0.040 |
Why?
|
| Surveys and Questionnaires | 2 | 2018 | 2504 | 0.040 |
Why?
|
| Time Management | 1 | 1998 | 9 | 0.040 |
Why?
|
| Consumer Advocacy | 1 | 1998 | 10 | 0.040 |
Why?
|
| Organizational Case Studies | 1 | 1998 | 27 | 0.040 |
Why?
|
| Time and Motion Studies | 1 | 1998 | 21 | 0.040 |
Why?
|
| Drinking Behavior | 1 | 2018 | 13 | 0.040 |
Why?
|
| Hospitals, Urban | 1 | 1998 | 54 | 0.040 |
Why?
|
| Military Personnel | 1 | 2019 | 85 | 0.040 |
Why?
|
| Hospitals, Teaching | 1 | 1998 | 116 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2023 | 797 | 0.040 |
Why?
|
| Trauma Centers | 1 | 1998 | 116 | 0.040 |
Why?
|
| Heart Rate | 1 | 2020 | 492 | 0.040 |
Why?
|
| Medical Staff, Hospital | 1 | 1998 | 107 | 0.040 |
Why?
|
| Health Care Surveys | 1 | 1998 | 278 | 0.040 |
Why?
|
| Databases as Topic | 1 | 2017 | 92 | 0.040 |
Why?
|
| Infusions, Intraventricular | 1 | 2017 | 5 | 0.040 |
Why?
|
| Forecasting | 2 | 2016 | 305 | 0.040 |
Why?
|
| Risk Factors | 2 | 2019 | 5420 | 0.040 |
Why?
|
| Inflammation | 1 | 2022 | 923 | 0.040 |
Why?
|
| Europe | 1 | 2017 | 309 | 0.040 |
Why?
|
| Age of Onset | 1 | 2017 | 310 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2018 | 506 | 0.040 |
Why?
|
| Temporal Lobe | 1 | 2017 | 173 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2001 | 747 | 0.040 |
Why?
|
| Switzerland | 1 | 2016 | 17 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2008 | 3361 | 0.040 |
Why?
|
| United States | 2 | 2003 | 6680 | 0.030 |
Why?
|
| Eating | 1 | 2017 | 166 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2018 | 306 | 0.030 |
Why?
|
| Medication Adherence | 1 | 2017 | 129 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2022 | 2231 | 0.030 |
Why?
|
| Communication | 1 | 1999 | 442 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2018 | 373 | 0.030 |
Why?
|
| Neurology | 1 | 2016 | 70 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 861 | 0.030 |
Why?
|
| Research Design | 1 | 1998 | 594 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2015 | 334 | 0.030 |
Why?
|
| Gene Expression | 1 | 2018 | 1284 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 1019 | 0.030 |
Why?
|
| Nitriles | 1 | 2014 | 149 | 0.030 |
Why?
|
| Clinical Competence | 1 | 1998 | 756 | 0.030 |
Why?
|
| Phenytoin | 1 | 2012 | 16 | 0.030 |
Why?
|
| Phenobarbital | 1 | 2012 | 33 | 0.030 |
Why?
|
| Philosophy, Medical | 1 | 1992 | 17 | 0.030 |
Why?
|
| Industry | 1 | 1992 | 16 | 0.030 |
Why?
|
| Aircraft | 1 | 1992 | 20 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2017 | 1924 | 0.030 |
Why?
|
| Transportation of Patients | 1 | 1992 | 32 | 0.030 |
Why?
|
| Drug Interactions | 1 | 2012 | 248 | 0.030 |
Why?
|
| Program Development | 1 | 1992 | 125 | 0.030 |
Why?
|
| Obesity | 1 | 2018 | 964 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2012 | 596 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 3642 | 0.020 |
Why?
|
| Sex Factors | 1 | 2012 | 1054 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 1620 | 0.020 |
Why?
|
| Verbal Behavior | 1 | 2008 | 32 | 0.020 |
Why?
|
| Dominance, Cerebral | 1 | 2008 | 66 | 0.020 |
Why?
|
| Semantics | 1 | 2008 | 50 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2015 | 4215 | 0.020 |
Why?
|
| Motor Cortex | 1 | 2008 | 195 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2008 | 478 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2008 | 549 | 0.020 |
Why?
|
| Doxycycline | 1 | 2004 | 27 | 0.020 |
Why?
|
| Inhalation | 1 | 2004 | 31 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2004 | 132 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 6513 | 0.010 |
Why?
|
| Radiography | 1 | 2004 | 811 | 0.010 |
Why?
|
| Planning Techniques | 1 | 1992 | 10 | 0.010 |
Why?
|
| Health Services Research | 1 | 1992 | 136 | 0.010 |
Why?
|
| Data Collection | 1 | 1992 | 372 | 0.010 |
Why?
|